Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–52.
Google Scholar
Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.
Google Scholar
Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016;16:413–30.
Google Scholar
Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.
Google Scholar
Kayser S, Levis MJ. Updates on targeted therapies for acute myeloid leukaemia. Br J Haematol. 2022;196:316–28.
Google Scholar
Xu Y, Milazzo JP, Somerville TDD, Tarumoto Y, Huang Y-H, Ostrander EL, et al. A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia. Cancer Cell. 2018;33:13–28.e8.
Google Scholar
Bhagwat AS, Vakoc CR. Targeting transcription factors in cancer. Trends Cancer. 2015;1:53–65.
Google Scholar
Bradner JE, Hnisz D, Young RA. Transcriptional addiction in cancer. Cell. 2017;168:629–43.
Google Scholar
Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564–.e16.
Google Scholar
Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478:524–8.
Google Scholar
Katti A, Diaz BJ, Caragine CM, Sanjana NE, Dow LE. CRISPR in cancer biology and therapy. Nat Rev Cancer. 2022;22:259–79.
Google Scholar
Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, et al. Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet. 2017;49:1779–84.
Google Scholar
Cao Z, Yu S, Peng J, Barrett DR, Liu Y, Sussman JH, et al. CRISPR-based functional genomics for dissecting therapeutic dependency in primary acute myeloid leukemia samples. Mol Cell. 2026;86:968–85.e7.
Google Scholar
Zhang P, Cao Z, Pan X, Liu Y, Castro C, Kim WJ, et al. Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignancies. Cancer Discov. 2025;15:2530–53.
Google Scholar
Tzelepis K, Rausch O, Kouzarides T. RNA-modifying enzymes and their function in a chromatin context. Nat Struct Mol Biol. 2019;26:858–62.
Google Scholar
Hentze MW, Sommerkamp P, Ravi V, Gebauer F. Rethinking RNA-binding proteins: Riboregulation challenges prevailing views. Cell. 2025;188:4811–27.
Google Scholar
Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol. 2007;8:479–90.
Google Scholar
Lee SC-W, Abdel-Wahab O. Therapeutic targeting of splicing in cancer. Nat Med. 2016;22:976–86.
Google Scholar
Lewis AM, Weis K, Abdel-Wahab O. RNA splicing as a therapeutic target in cancer. Annu Rev Pharmacol Toxicol. 2026;66:441–63.
Google Scholar
Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millán-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature. 2017;552:126–31.
Google Scholar
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369–76.
Google Scholar
Yamauchi T, Masuda T, Canver MC, Seiler M, Semba Y, Shboul M, et al. Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS. Cancer Cell. 2018;33:386–400.e5.
Google Scholar
Wang E, Lu SX, Pastore A, Chen X, Imig J, Chun-Wei Lee S, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369–21.e7.
Google Scholar
Wang E, Pineda JMB, Kim WJ, Chen S, Bourcier J, Stahl M, et al. Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Cancer Cell. 2023;41:164–80.e8.
Google Scholar
Palanichamy JK, Tran TM, Howard JM, Contreras JR, Fernando TR, Sterne-Weiler T, et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J Clin Invest. 2016;126:1495–511.
Google Scholar
Zhang M, Hyle J, Chen X, Xin Y, Jin Y, Zhang J, et al. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome Biol. 2024;25:16.
Google Scholar
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127–41.
Google Scholar
Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell. 2018;22:191–205.e9.
Google Scholar
Fu X-D, Mobley WC. Therapeutic potential of PTB inhibition through converting glial cells to neurons in the brain. Annu Rev Neurosci. 2023;46:145–65.
Google Scholar
Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon Y-S, et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell. 2009;36:996–1006.
Google Scholar
Hu J, Qian H, Xue Y, Fu X-D. PTB/nPTB: master regulators of neuronal fate in mammals. Biophys Rep. 2018;4:204–14.
Google Scholar
Xiao R, Chen J-Y, Liang Z, Luo D, Chen G, Lu ZJ, et al. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell. 2019;178:107–121e18.
Google Scholar
Xing L, Guo X, Zhang X, Wang Y, He F, Ren J. PTBP1 is a potential indicator of disease progression in acute myeloid leukemia. J Investig Med. 2024;72:891–9.
Google Scholar
Zhang Q-X, Pan Y-M, Xiao H-L, An N, Deng S-S, Du X. Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy. Neoplasma. 2022;69:1198–208.
Google Scholar
Dhir A, Ethell A, Watkins R, Lam C, Tur-Rodriguez K, Persinger J, et al. The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival. bioRxiv. 2025;2025:654547 05.16.
Garcia-Cuellar M-P, Lawlor J, Böttcher M, Mougiakakos D, Metzler M, Slany RK. Exploitable metabolic dependencies in MLL-ENL-induced leukemia. Blood Adv. 2020;4:3626–38.
Google Scholar
Carico C, Cui J, Acton A, Placzek WJ. Polypyrimidine tract binding protein 1 (PTBP1) contains a novel regulatory sequence, the rBH3, that binds the prosurvival protein MCL1. J Biol Chem. 2023;299:104778.
Google Scholar
Shi J, Wang E, Milazzo JP, Wang Z, Kinney JB, Vakoc CR. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol. 2015;33:661–7.
Google Scholar
Cook KB, Kazan H, Zuberi K, Morris Q, Hughes TR. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 2011;39:D301–308.
Google Scholar
Cao Z, Budinich KA, Huang H, Ren D, Lu B, Zhang Z, et al. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Mol Cell. 2021;81:3604–22.e10.
Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.
Google Scholar
Dou Z, Xu C, Donahue G, Shimi T, Pan J-A, Zhu J, et al. Autophagy mediates degradation of nuclear lamina. Nature. 2015;527:105–9.
Google Scholar
Choi H, Larsen B, Lin Z-Y, Breitkreutz A, Mellacheruvu D, Fermin D, et al. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods. 2011;8:70–73.
Google Scholar
Snel B, Lehmann G, Bork P, Huynen MA. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 2000;28:3442–4.
Google Scholar
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
Google Scholar
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
Google Scholar
Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199–W205.
Google Scholar
Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.
Google Scholar
Wang Y, Xie Z, Kutschera E, Adams JI, Kadash-Edmondson KE, Xing Y. rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data. Nat Protoc. 2024;19:1083–104.
Google Scholar
Vaquero-Garcia J, Barrera A, Gazzara MR, González-Vallinas J, Lahens NF, Hogenesch JB, et al. A new view of transcriptome complexity and regulation through the lens of local splicing variations. Elife. 2016;5:e11752.
Google Scholar
Van Nostrand EL, Nguyen TB, Gelboin-Burkhart C, Wang R, Blue SM, Pratt GA, et al. Robust, cost-effective profiling of RNA binding protein targets with single-end enhanced crosslinking and immunoprecipitation (seCLIP). Methods Mol Biol. 2017;1648:177–200.
Google Scholar
Liu F, Clark W, Luo G, Wang X, Fu Y, Wei J, et al. ALKBH1-Mediated tRNA demethylation Regulates Translation. Cell. 2016;167:816–28.e16.
Google Scholar
ENCODE Project ConsortiumAn integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
Google Scholar
Luo E-C, Nathanson JL, Tan FE, Schwartz JL, Schmok JC, Shankar A, et al. Large-scale tethered function assays identify factors that regulate mRNA stability and translation. Nat Struct Mol Biol. 2020;27:989–1000.
Google Scholar
Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10–12.
Google Scholar
Bao W, Kojima KK, Kohany O. Repbase Update, a database of repetitive elements in eukaryotic genomes. Mob DNA. 2015;6:11.
Google Scholar
Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576–89.
Google Scholar
Goldfarb T, Kodali VK, Pujar S, Brover V, Robbertse B, Farrell CM, et al. NCBI RefSeq: reference sequence standards through 25 years of curation and annotation. Nucleic Acids Res. 2025;53:D243–D257.
Google Scholar
Vu LP, Prieto C, Amin EM, Chhangawala S, Krivtsov A, Calvo-Vidal MN, et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat Genet. 2017;49:866–75.
Google Scholar
Li Z, Zhang Z, Li Y, Arnovitz S, Chen P, Huang H, et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood. 2013;121:1422–31.
Google Scholar
Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9. Nature. 2006;442:818–22.
Google Scholar
Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7:823–33.
Google Scholar
Tarumoto Y, Lu B, Somerville TDD, Huang Y-H, Milazzo JP, Wu XS, et al. LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia. Mol Cell. 2018;69:1017–27.e6.
Google Scholar
Lu B, Klingbeil O, Tarumoto Y, Somerville TDD, Huang Y-H, Wei Y, et al. A transcription factor addiction in leukemia imposed by the MLL promoter sequence. Cancer Cell. 2018;34:970–81.e8.
Google Scholar
Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev. 2011;25:1628–40.
Google Scholar
Mickleburgh I, Kafasla P, Cherny D, Llorian M, Curry S, Jackson RJ, et al. The organization of RNA contacts by PTB for regulation of FAS splicing. Nucleic Acids Res. 2014;42:8605–20.
Google Scholar
Oberstrass FC, Auweter SD, Erat M, Hargous Y, Henning A, Wenter P, et al. Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science. 2005;309:2054–7.
Google Scholar
Carico C, Placzek WJ. Reviewing PTBP1 domain modularity in the pre-genomic era: a foundation to guide the next generation of exploring PTBP1 structure–function relationships. Int J Mol Sci. 2023;24:11218.
Google Scholar
Han A, Stoilov P, Linares AJ, Zhou Y, Fu X-D, Black DL. De Novo prediction of PTBP1 binding and splicing targets reveals unexpected features of its RNA recognition and function. PLoS Comput Biol. 2014;10:e1003442.
Google Scholar
Rehn M, Wenzel A, Frank A-K, Schuster MB, Pundhir S, Jørgensen N, et al. PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents. Cell Rep. 2022;39:110793.
Google Scholar
Kurtz KJ, Conneely SE, O’Keefe M, Wohlan K, Rau RE. Murine Models of Acute Myeloid Leukemia. Front Oncol. 2022;12:854973.
Google Scholar
Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol. 2011;29:79–83.
Google Scholar
Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe J-S, et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 2013;27:2648–62.
Google Scholar
Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M, et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood. 2009;113:2375–85.
Google Scholar
Pingul BY, Huang H, Chen Q, Alikarami F, Zhang Z, Qi J, et al. Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia. iScience. 2022;25:105139.
Google Scholar
Liss F, Frech M, Wang Y, Giel G, Fischer S, Simon C, et al. IRF8 Is an AML-specific susceptibility factor that regulates signaling pathways and proliferation of AML Cells. Cancers (Basel). 2021;13:764.
Google Scholar
Harada T, Heshmati Y, Kalfon J, Perez MW, Xavier Ferrucio J, Ewers J, et al. A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia. Genes Dev. 2022;36:368–89.
Google Scholar
Issa GC, Aldoss I, DiPersio J, Cuglievan B, Stone R, Arellano M, et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature. 2023;615:920–4.
Google Scholar
Krivtsov AV, Evans K, Gadrey JY, Eschle BK, Hatton C, Uckelmann HJ, et al. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia. Cancer Cell. 2019;36:660–73.e11.
Google Scholar
Issa GC, Aldoss I, Thirman MJ, DiPersio J, Arellano M, Blachly JS, et al. Menin inhibition With Revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101). J Clin Oncol. 2025;43:75–84.
Google Scholar
Daver N, Schlenk RF, Russell NH, Levis MJ. Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019;33:299–312.
Google Scholar
Canté-Barrett K, Pieters R, Meijerink JPP. Myocyte enhancer factor 2C in hematopoiesis and leukemia. Oncogene. 2014;33:403–10.
Google Scholar
Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. J Hematol Oncol. 2015;8:115.
Google Scholar
Du Y, Spence SE, Jenkins NA, Copeland NG. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood. 2005;106:2498–505.
Google Scholar
Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative Pre-mRNA splicing. Mol Cell. 2007;27:435–48.
Google Scholar
Boutz PL, Stoilov P, Li Q, Lin C-H, Chawla G, Ostrow K, et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 2007;21:1636–52.
Google Scholar
Van Nostrand EL, Freese P, Pratt GA, Wang X, Wei X, Xiao R, et al. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583:711–9.
Google Scholar
Chourasia AH, Majeski H, Pasis A, Erdman P, Oke A, Hecht D, et al. BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors. JCO. 2022;40:7025.
Google Scholar
Berdeja J, Ailawadhi S, Horwitz SM, Matous JV, Mehta-Shah N, Martin T, et al. A Phase 1 study of CFT7455, a novel degrader of IKZF1/3, in multiple myeloma and non-Hodgkin lymphoma. Blood. 2021;138:1675.
Google Scholar
Aubrey BJ, Cutler JA, Bourgeois W, Donovan KA, Gu S, Hatton C, et al. IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nat Cancer. 2022;3:595–613.
Google Scholar
Marke R, Leeuwen FN, van, Scheijen B. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2018;103:565–74.
Google Scholar
Nakase K, Ishimaru F, Avitahl N, Dansako H, Matsuo K, Fujii K, et al. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res. 2000;60:4062–5.
Google Scholar
Tarumoto Y, Lin S, Wang J, Milazzo JP, Xu Y, Lu B, et al. Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo. Blood. 2020;135:56–70.
Google Scholar
Shi J, Wang E, Zuber J, Rappaport A, Taylor M, Johns C, et al. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9; NrasG12D acute myeloid leukemia. Oncogene. 2013;32:930–8.
Google Scholar
Tanaka S, Miyagi S, Sashida G, Chiba T, Yuan J, Mochizuki-Kashio M, et al. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood. 2012;120:1107–17.
Google Scholar
Kühn MWM, Song E, Feng Z, Sinha A, Chen C-W, Deshpande AJ, et al. Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia. Cancer Discov. 2016;6:1166–81.
Google Scholar
Sun Y-M, Wang W-T, Zeng Z-C, Chen T-Q, Han C, Pan Q, et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019;134:1533–46.
Google Scholar
Prieto C, Nguyen DTT, Liu Z, Wheat J, Perez A, Gourkanti S, et al. Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat Cancer. 2021;2:741–57.
Google Scholar
Han T, Goralski M, Gaskill N, Capota E, Kim J, Ting TC, et al. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science. 2017;356:eaal3755.
Google Scholar
Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M et al. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell 2021;184:4032–47.
Google Scholar
Schmeing S, Amrahova G, Bigler K, Chang J-Y, Openy J, Pal S et al. Rationally designed stapled peptides allosterically inhibit PTBP1–RNA-binding. Chem Sci. 2023;14:8269–78.
Google Scholar
Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597–601.
Google Scholar
El Marabti E, Abdel-Wahab O, et al. Therapeutic modulation of RNA splicing in malignant and non-malignant disease. Trends Mol Med. 2021;27:643–59.
Google Scholar
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79–96.e11.
Google Scholar
Schoonenberg VAC, Cole MA, Yao Q, Macias-Treviño C, Sher F, Schupp PG, et al. CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis. Genome Biol. 2018;19:169.
Google Scholar
Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cells Syst. 2015;1:417–25.
Google Scholar
